Crossmark Global Holdings Inc. Has $5.63 Million Stake in DaVita Inc. (NYSE:DVA)

Crossmark Global Holdings Inc. grew its position in DaVita Inc. (NYSE:DVA - Free Report) by 19.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,769 shares of the company's stock after acquiring an additional 6,000 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in DaVita were worth $5,625,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. UMB Bank n.a. lifted its position in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after buying an additional 76 shares during the period. Copia Wealth Management bought a new position in shares of DaVita during the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. bought a new position in shares of DaVita during the 4th quarter worth approximately $41,000. Coppell Advisory Solutions LLC lifted its position in shares of DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares during the period. Finally, Canada Post Corp Registered Pension Plan bought a new position in DaVita in the 4th quarter valued at $55,000. Institutional investors own 90.12% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on DVA. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Truist Financial cut their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $164.50.

DaVita Trading Up 0.6%

Shares of NYSE DVA traded up $0.91 during midday trading on Thursday, hitting $142.75. The stock had a trading volume of 180,844 shares, compared to its average volume of 865,945. The company's 50-day simple moving average is $140.16 and its 200 day simple moving average is $149.11. The firm has a market cap of $10.78 billion, a P/E ratio of 14.15, a price-to-earnings-growth ratio of 0.99 and a beta of 1.11. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm's revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.26 earnings per share. Research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.